Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 18'th Mar 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Fresenius (FMS) is a Strong Value Stock
10:45am, Friday, 14'th Mar 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum
08:00am, Thursday, 13'th Mar 2025
In 2024, the operating model to deliver the highest quality of patient care was further optimized by enhancing financial returns, and creating value for shareholders Fresenius Medical Care delivered 1
FMS Stock Gains Following Stake Sale to Reduce Debt & Boost Profit
04:00pm, Thursday, 06'th Mar 2025
Fresenius Medical Care's parent company sells 10.6 million shares, the proceeds of which will be used to reduce its leverage and achieve higher profits in 2025.
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
10:45am, Tuesday, 04'th Mar 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Fresenius Medical Care's stock falls on Fresenius' stake sale
03:57am, Tuesday, 04'th Mar 2025
Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in the company.
Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
12:50pm, Thursday, 27'th Feb 2025
FMS, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and su
Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y
12:35pm, Wednesday, 26'th Feb 2025
FMS' fourth-quarter results showcase a strong segmental performance along with providing full year 2025 outlook for revenue growth and operating income.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
10:45am, Wednesday, 26'th Feb 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
07:00am, Tuesday, 25'th Feb 2025
Organic revenue growth1 of 4% driven by Care Enablement and Care Delivery Underlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full year Accumulated savi
Fresenius Medical Care slightly beats market estimates in fourth quarter
01:14am, Tuesday, 25'th Feb 2025
Fresenius Medical Care , the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery a
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
08:00am, Monday, 24'th Feb 2025
Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.
The Company's patent pending silicon-enhanced spheroidized graphite technology represents a breakthrough in lithium-ion battery performance. OTTAWA, ON / ACCESS Newswire / February 10, 2025 / Focus Gr
Fresenius Medical Care: A 'Buy' Going Into 2025
06:20am, Friday, 31'st Jan 2025
Fresenius Medical Care is a leader in global kidney care, showing significant growth and an 18.5% increase since my last article. The company is attractively valued, trading at less than 18.5x P/E, wi
Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know
01:16pm, Tuesday, 07'th Jan 2025
Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
